Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET

被引:46
作者
Bullich, Santiago [1 ]
Villemagne, Victor L. [2 ,3 ]
Catafau, Ana M. [1 ]
Jovalekic, Aleksandar [1 ]
Koglin, Norman [1 ]
Rowe, Christopher C. [2 ,3 ]
De Santi, Susan [4 ]
机构
[1] Piramal Imaging GmbH, Berlin, Germany
[2] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia
[3] Univ Melbourne, Austin Hlth, Dept Mol Imaging, Melbourne, Vic, Australia
[4] Piramal Pharma Inc, Boston, MA USA
关键词
amyloid beta; florbetaben PET; longitudinal; reference region; MILD COGNITIVE IMPAIRMENT; VOLUME EFFECT CORRECTION; WHITE-MATTER REFERENCE; ALZHEIMERS-DISEASE; QUANTITATIVE-ANALYSIS; DEPOSITION; QUANTIFICATION; VARIABILITY; PLAQUES; RATIOS;
D O I
10.2967/jnumed.116.187351
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Accurate measurement of changes in amyloid-b (A beta) deposition over time is important in longitudinal studies, particularly in anti-A beta therapeutic trials. To achieve this, the optimal reference region (RR) must be selected to reduce variance of A beta PET measurements, allowing early detection of treatment efficacy. The aim of this study was to determine the RR that allows earlier detection of subtle A beta changes using F-18-florbetaben PET. Methods: Forty-five patients with mild cognitive impairment (mean age +/- SD, 72.69 +/- 6.54 y; 29 men/16 women) who underwent up to 3 F-18-florbetaben scans were included. Baseline scans were visually classified as high (A beta+) or low (A beta-) amyloid. Six cortical regions were quantified using a standardized region-ofinterest atlas applied to the spatially normalized gray matter image obtained from segmentation of the baseline T1-weighted volumetric MRI. Four RRs (cerebellar gray matter [CGM], whole cerebellum [WCER], pons, and subcortical white matter [SWM]) were studied. The SUV ratio (SUVR) for each RR was calculated by dividing cortex activity by RR activity, with a composite SUVR averaged over +/- cortical regions. SUVR increase from baseline to 1 and 2 y, and percentage A beta deposition per year, were assessed across A beta+ and A beta- groups. Results: SUVs for any RR were not significantly different over time. Percentage A beta accumulation per year derived from composite SUVR was 0.10 +/- 1.72 (A beta-) and 1.36 +/- 1.98 (A beta+) (P = 0.02) for CGM and 0.13 +/- 1.47 and 1.32 +/- 1.75 (P = 0.01), respectively, for WCER. Compared with baseline, the composite SUVR increase in A beta+ scans was significantly larger than in A beta- scans at 1 y (P = 0.04 [CGM]; P = 0.03 [WCER]) and 2 y (P = 0.02 [CGM]; P = 0.01 [WCER]) using these 2 RRs. Significant SUVR changes using the pons as the RR were detected only at 2 y (P = 0.46 [1 y], P = 0.001 [2 y]). SUVR using the SWM as the RR showed no significant differences at either followup (P = 0.39 [1 y], P = 0.09 [2 y]). Conclusion: RR selection influences reliable early measurement of A beta changes over time. Compared with SWM and pons, which do not fulfil the RR requirements and have limited sensitivity to detect A beta changes, cerebellar RRs are recommended for F-18-florbetaben PET because they allow earlier detection of A beta accumulation.
引用
收藏
页码:1300 / 1306
页数:7
相关论文
共 29 条
[1]  
[Anonymous], ALZHEIMERS DEMENT S
[2]   Prediction of Amyloid-β Pathology in Amnestic Mild Cognitive Impairment with Neuropsychological Tests [J].
Bahar-Fuchs, Alex ;
Villemagne, Victor ;
Ong, Kevin ;
Chetelat, Gael ;
Lamb, Fiona ;
Reininger, Cornelia B. ;
Woodward, Michael ;
Rowe, Christopher C. .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (02) :451-462
[3]  
Barthel H, 2015, J NUCL MED, V56
[4]   Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction [J].
Brendel, Matthias ;
Hoegenauer, Marcus ;
Delker, Andreas ;
Sauerbeck, Julia ;
Bartenstein, Peter ;
Seibyl, John ;
Rominger, Axel .
NEUROIMAGE, 2015, 108 :450-459
[5]  
Bullich S, 2016, J NUCL MED, V57
[6]   Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios? [J].
Catafau, Ana M. ;
Bullich, Santiago ;
Seibyl, John P. ;
Barthel, Henryk ;
Ghetti, Bernardino ;
Leverenz, James ;
Ironside, James W. ;
Schulz-Schaeffer, Walter J. ;
Hoffmann, Anja ;
Sabri, Osama .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (11) :1740-1745
[7]   Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region [J].
Chen, Kewei ;
Roontiva, Auttawut ;
Thiyyagura, Pradeep ;
Lee, Wendy ;
Liu, Xiaofen ;
Ayutyanont, Napatkamon ;
Protas, Hillary ;
Luo, Ji Luo ;
Bauer, Robert ;
Reschke, Cole ;
Bandy, Daniel ;
Koeppe, Robert A. ;
Fleisher, Adam S. ;
Caselli, Richard J. ;
Landau, Susan ;
Jagust, William J. ;
Weiner, Michael W. ;
Reiman, Eric M. .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) :560-566
[8]  
De Santi S, 2016, J NUCL MED, V57
[9]   Acceleration of cortical thinning in familial Alzheimer's disease [J].
Knight, W. D. ;
Kim, L. G. ;
Douiri, A. ;
Frost, C. ;
Rossor, M. N. ;
Fox, N. C. .
NEUROBIOLOGY OF AGING, 2011, 32 (10) :1765-1773
[10]   Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios [J].
Landau, Susan M. ;
Fero, Allison ;
Baker, Suzanne L. ;
Koeppe, Robert ;
Mintun, Mark ;
Chen, Kewei ;
Reiman, Eric M. ;
Jagust, William J. .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) :567-574